GlassScriptPhysician profile
Hector O Campbell
NPI 1093049926
$27,047.67
in general payments reported to CMS, 2019-2025
20 companies · $3,694 in 2025
The $3,694 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,250 · 2020: $392 · 2021: $2,943 · 2022: $4,188 · 2023: $5,257 · 2024: $8,324 · 2025: $3,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,038 · Travel and Lodging: $4,702 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,938 · Food and Beverage: $2,682 · Long Term Medical Supply Or Device Loan: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,037.50 |
| Travel and Lodging | $4,702.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,938.00 |
| Food and Beverage | $2,682.09 |
| Long Term Medical Supply Or Device Loan | $1,915.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $9,673.20 | 2022-2024 | Puraply Wound Matrix, Affinity, Nushield |
| Abbvie INC. | $4,934.10 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants, Alloderm |
| Tela Bio, INC. | $3,432.52 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $2,796.11 | 2019-2022 | |
| Integra Lifesciences Corporation | $2,375.60 | 2019-2025 | Durasorb Monofilament Mesh, Acell, Integra |
| Arthrex, INC. | $1,363.84 | 2021 | |
| Stryker Corporation | $559.44 | 2022 | |
| Axogen | $354.84 | 2019-2021 | |
| Kairos Surgical INC | $324.32 | 2021 | |
| Covidien LP | $298.70 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $276.69 | 2019-2023 | Xiaflex |
| Checkpoint Surgical, INC | $173.79 | 2024 | Checkpoint Stimulators |
| Karl Storz Endoscopy-America | $118.65 | 2022 | |
| Alafair Biosciences, INC. | $111.82 | 2024 | Versawrap |
| Sientra, INC. | $94.28 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $78.27 | 2025 | |
| Smith+Nephew, INC. | $29.32 | 2019-2021 | |
| Acumed LLC | $21.87 | 2020 | |
| Solventum Corporation | $16.85 | 2025 | 3m Cavilon, V.A.C. Veraflo Cleanse Choice, Prevena |
| Musculoskeletal Transplant Foundation INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.